Social Media Ideas for Modules & Upstream Manufacturing

<![CDATA[DARPA's Role in Bringing Manufacturing Back to the US]]>

<![CDATA[Utilizing 100-Percent Domestic Additive Manufacturing: Q&A with Kyle Smith]]>

<![CDATA[The Benefits and Challenges of 100 Percent US-Based Manufacturing]]>

<![CDATA[Additive Manufacturing's Application in Pharma and Biotech]]>

<![CDATA[Targeted Onshoring's Impact on Domestic Pharma Manufacturing]]>

Why US-manufactured pharmaceutical packaging equipment matters

As manufacturers modernize operations, the origin of their equipment is a strategic consideration.

Shilpa Commissions Integrated ADC Drug Substance GMP Manufacturing Facility

The manufacturing of highly potent compounds has been a core pillar of Shilpa’s identity, and this ADC drug substance facility adds a new sophisticated dimension to the Shilpa grou...

FDA Issues Proposal to Streamline Registration for Advanced Distributed Manufacturers

Distributed manufacturing establishments operate a hub-and-spoke model, with a central quality oversight hub and multiple equivalent manufacturing units at different locations. Reg...

GVRP, StepsBio set up CoE for formulations R&D in Bengaluru

GSRC is designed to tackle complex formulation challenges by combining advanced scientific infrastructure with specialised workflows for drug delivery systems, sterile injectables,...

<![CDATA[Supply Chain Modernization is Now Strategy: What Pharma Leaders Must Get Right]]>

<![CDATA[Realistic Timelines for Pharma Manufacturing Reshoring]]>

Fujifilm Selected with Six Others in FDA PreCheck Pilot Manufacturing Program

Fujifilm’s Holly Springs facility is one of North America's largest end-to-end cell culture biopharmaceutical manufacturing facilities and represents a key node in the company’s gr...

End-to-end: Curia drives supply and scale for steroid and hormonal therapies

Explore how Curia tackles steroid manufacturing complexity, from early development to scaled, end-to-end commercial supply. The post End-to-end: Curia drives supply and scale for s...

The co-manufacturer’s dilemma: How MattPak learned to say yes to more business

Ninety-eight percent uptime, no temp labor, a facility doubling in size. MattPak's automation story.

<![CDATA[Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last]]...

For biopharma manufacturing at speed and scale, the future is flexible

Biopharma development has long trended toward specialized and personalized therapies such as cell and gene therapies, antibody-drug conjugates, and monoclonal antibodies (mAbs), am...

<![CDATA[Improving Global Pharma Operations with Data]]>

<![CDATA[Pharmaceutical Cold-Chain Logistics: Protecting Integrity from End to End (May 2026)]]>

Cytiva Completes Doubling of Utah Site’s Liquid Media Production Capacity

In a wide-ranging interview, Pierre-Alain Ruffieux, Cytiva’s group executive, bioprocess, discusses completion of the doubling of the company’s liquid media production capacity in...

Supplier Quality Equals Device Quality: Eliminating Quality Failures at the Handoff

Some of the most disruptive quality failures in medical manufacturing are not found on the production floor. They are built into the handoff between the supplier and manufacturer e...

Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXUâ„¢ Wound Care Program

Activities are intended to support regulatory testing and the Company’s planned first-quarter 2027 FDA 510(k) premarket notification submission

<![CDATA[What Pharma Leaders Must Get Right for Supply Chain Modernization Strategy]]>

<![CDATA[How 3D Printing Speeds Up Drug Production]]>

Inside modern supplement manufacturing: How automated filling lines are raising the quality bar

Automation has redefined supplement manufacturing, with state-of-the-art filling lines now setting higher standards of quality and efficiency. These systems bring advanced technolo...